tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Lapides, 120 are a HOLD (48.78%), 104 are a BUY (42.28%), 22 are a SELL (8.94%).
Analyst Michael Lapides, carries an average stock price target met ratio of 78.22% that have a potential upside of 37.79% achieved within 848 days. Previously, Michael Lapides worked at EVERCORE, WELLS FARGO, GOLDMAN SACHS, JPMORGAN, TRUIST, MORGAN STANLEY.
Michael Lapides’s has documented 496 price targets and ratings displayed on 63 stocks. The coverage was on Utilities, Energy, Industrials, Consumer Cyclical, Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on MPW, Medical Properties Trust at 29-May-2024.
Analyst best performing recommendations are on IGMS (IGM BIOSCIENCES).
The best stock recommendation documented was for IGMS (IGM BIOSCIENCES) at 11/15/2023. The price target of $8 was fulfilled within 36 days with a profit of $2.1 (35.59%) receiving and performance score of 9.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Apr-2024
$132
$1.79 (1.37%)
$120
Buy Since 06-May-2025
$149
$18.79 (14.43%)
$148
8 days ago
(28-Oct-2026)
11/17 (64.71%)
$19.66 (15.20%)
449
Buy Since 15-Apr-2026
$146
$15.79 (12.13%)
$147
15 days ago
(21-Oct-2026)
16/19 (84.21%)
$15.36 (11.76%)
564
Buy Since 11-Mar-2020
$130
$-0.21 (-0.16%)
$128
16 days ago
(20-Oct-2026)
82/84 (97.62%)
$2.61 (2.05%)
897
Hold Since 25-Dec-2024
$135
$4.79 (3.68%)
$139
18 days ago
(18-Oct-2026)
12/14 (85.71%)
$10.28 (8.24%)
209
